MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Cardiology

  • Home
  • Specialties
  • Cardiology
  • Page 12
Posted inCardiology news Radiology

Optimizing Needle Thoracostomy in Obese Patients: Chest Wall Thickness Influences on Site Selection and Needle Length

Posted by By Zhang Paul 07/24/2026
Highlight 1. Chest wall thickness (CWT) varies significantly between anatomical sites used for needle thoracostomy…
Read More
Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization: Bridging the Gap Between Prescription and Sustained Use
Posted inCardiology Clinical Updates news

Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization: Bridging the Gap Between Prescription and Sustained Use

Posted by By MedXY 07/24/2026
This review synthesizes contemporary evidence on initiation, adherence, and persistence of guideline-directed medical therapy after heart failure hospitalization, highlighting critical gaps and strategies to improve long-term patient outcomes.
Read More
Olorofim for Poorly Controlled Disseminated Coccidioidomycosis: Phase 2b Clinical Efficacy and Safety Insights
Posted inCardiology Clinical Updates Internal Medicine news

Olorofim for Poorly Controlled Disseminated Coccidioidomycosis: Phase 2b Clinical Efficacy and Safety Insights

Posted by By MedXY 07/24/2026
This review synthesizes key findings evaluating olorofim's clinical effectiveness and safety in patients with refractory disseminated coccidioidomycosis, emphasizing its potential role amid limited treatment options.
Read More
Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical Outcomes
Posted inCardiology Diabetes & Endocrinology news

Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical Outcomes

Posted by By MedXY 07/22/2026
This analysis of the SOUL trial shows oral semaglutide reduces major cardiovascular events, with greater benefits linked to higher baseline HbA1c and larger HbA1c reductions, while BMI changes did not significantly affect outcomes.
Read More
GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity
Posted inCardiology Diabetes & Endocrinology news

GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity

Posted by By MedXY 07/22/2026
GLP-1 receptor agonists significantly reduce atherosclerosis progression, inflammatory biomarkers, and cardiovascular events independent of glycaemic control and obesity status, evidenced by robust preclinical and large-scale clinical data.
Read More
Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial
Posted inCardiology Clinical Updates Diabetes & Endocrinology news

Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial

Posted by By MedXY 07/21/2026
Medically tailored groceries modestly improve HbA1c and significantly enhance food and nutrition security among Medicaid-insured adults with type 2 diabetes, supporting 'Food Is Medicine' strategies in chronic disease management.
Read More
Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning
Posted inCardiology news Pathology & Lab Medicine/Bệnh học

Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning

Posted by By MedXY 07/18/2026
This study introduces and validates a simplified machine learning-based equation for estimating LDL cholesterol, showing comparable accuracy to the original Martin-Hopkins method and improved ease of use.
Read More
Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb Risks
Posted inCardiology news

Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb Risks

Posted by By MedXY 07/18/2026
This article reviews recent advances in the medical management of peripheral artery disease, emphasizing comprehensive risk factor control, novel pharmacotherapies, and individualized approaches to improve cardiovascular and limb outcomes in affected patients.
Read More
Revolutionizing Myocardial Scar Detection: AI-Powered Contrast-Free MRI via Virtual Native Enhancement
Posted inAI Cardiology news

Revolutionizing Myocardial Scar Detection: AI-Powered Contrast-Free MRI via Virtual Native Enhancement

Posted by By MedXY 07/18/2026
A prospective multicenter study demonstrates that AI-driven virtual native enhancement (VNE) MRI can accurately detect and quantify myocardial scars without contrast agents, potentially reducing the need for gadolinium-based imaging in clinical cardiology.
Read More
Evaluating Riociguat in Early Pulmonary Vascular Disease: Insights from the ESRA Phase IIa Trial
Posted inCardiology news Respiratory

Evaluating Riociguat in Early Pulmonary Vascular Disease: Insights from the ESRA Phase IIa Trial

Posted by By MedXY 07/17/2026
The ESRA trial demonstrates that riociguat is safe and effectively reduces pulmonary vascular resistance in early pulmonary vascular disease, though secondary benefits remain unproven in this early-stage, mostly connective tissue disease-associated cohort.
Read More
Bridging the Gap: Improving Skilled Nursing Facility-to-Home Transitions for Heart Failure Patients
Posted inCardiology news

Bridging the Gap: Improving Skilled Nursing Facility-to-Home Transitions for Heart Failure Patients

Posted by By MedXY 07/16/2026
This study reveals significant gaps in discharge communication, self-care education, medication management, and follow-up coordination during skilled nursing facility-to-home transitions after heart failure hospitalization, highlighting the need for standardized workflows and enhanced cross-setting communication.
Read More
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease
Posted inCardiology news

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease

Posted by By MedXY 07/16/2026
This study compares the predictive value of non-HDL cholesterol and apolipoprotein B for atherosclerotic cardiovascular disease risk in individuals not on lipid-lowering medication.
Read More
Temporal Trends in Oral Anticoagulant Use and Clinical Outcomes Among Older Adults with Atrial Fibrillation: Insights from a Danish Nationwide Study and Contemporary Evidence
Posted inCardiology Clinical Updates news

Temporal Trends in Oral Anticoagulant Use and Clinical Outcomes Among Older Adults with Atrial Fibrillation: Insights from a Danish Nationwide Study and Contemporary Evidence

Posted by By MedXY 07/16/2026
Recent decades saw increased anticoagulant use and reduced stroke risk in elderly AF patients, especially with DOACs, but bleeding risks rise notably in very elderly patients, highlighting tailored management needs.
Read More
Coronary Artery Calcium and Statin Allocation in the Era of PREVENT: Evidence from MESA
Posted inCardiology news

Coronary Artery Calcium and Statin Allocation in the Era of PREVENT: Evidence from MESA

Posted by By MedXY 07/16/2026
This study assesses how coronary artery calcium (CAC) scoring refines statin eligibility using the new PREVENT risk calculator, emphasizing its value in borderline risk patients and cautioning against withholding statins solely for CAC 0 in high-risk individuals.
Read More
Hypoxia-Induced BACH1 Elevation Drives Pulmonary Hypertension via Activation of TGFBR2/SMAD Signaling
Posted inCardiology news Respiratory

Hypoxia-Induced BACH1 Elevation Drives Pulmonary Hypertension via Activation of TGFBR2/SMAD Signaling

Posted by By MedXY 07/15/2026
BACH1 stabilization under hypoxia promotes pulmonary hypertension by enhancing TGFBR2/SMAD pathway activity in pulmonary artery smooth muscle cells, suggesting BACH1 as a promising therapeutic target for PH.
Read More
Molecular Mutations and Cardiovascular Risks Shape Prognosis in Triple-Negative Essential Thrombocythemia
Posted inCardiology Hematology-Oncology news

Molecular Mutations and Cardiovascular Risks Shape Prognosis in Triple-Negative Essential Thrombocythemia

Posted by By MedXY 07/15/2026
This study reveals that specific gene mutations and cardiovascular risk factors significantly influence prognosis and thrombotic risk in triple-negative essential thrombocythemia, highlighting the importance of molecular profiling for personalized treatment.
Read More
HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine
Posted inCardiology news

HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine

Posted by By MedXY 07/14/2026
HERZCHECK demonstrates that mobile, telemedically supervised cardiac MRI enables early detection of subclinical preheart failure in at-risk individuals with cardiovascular risk factors in rural areas, identifying disease nearly seven years before symptomatic heart failure develops.
Read More
Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study
Posted inCardiology news OB/GYN & Women’s Health

Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study

Posted by By MedXY 07/14/2026
A comprehensive nationwide study reveals that maternal diabetes during pregnancy, particularly pregestational diabetes, significantly increases offspring's risk of early-onset cardiovascular diseases, mediated partly by perinatal complications.
Read More
Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts
Posted inCardiology news Public Health

Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts

Posted by By MedXY 07/14/2026
This study from two Spanish cohorts explores how moderate wine consumption within a Mediterranean diet impacts cardiovascular disease and mortality, suggesting modest benefits but advising cautious interpretation.
Read More
ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina
Posted inCardiology news

ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina

Posted by By MedXY 07/14/2026
The ORBITA-CTO multicenter, randomized, placebo-controlled trial demonstrates that PCI significantly improves angina symptoms and quality of life in patients with single-vessel CTO without bystander disease, compared to placebo.
Read More

Posts pagination

Previous page 1 … 10 11 12 13 14 … 25 Next page
  • The Laennec Technique: Advancing Standardization in Right Robotic Donor Hepatectomies
  • Assessing the Learning Curve of Robotic Left-Sided Pancreatectomy: Safety and Oncological Outcomes in a Multicenter International Study
  • Strategies to Minimize Coronary Malperfusion in Bioprosthetic Aortic Root Replacement
  • Bridging Gaps in Trauma Care: Assessing Trauma-Informed Communication in the Trauma Bay
  • Robotic Versus Laparoscopic Cholecystectomy: Balancing Safety, Efficacy, and Cost with a Novel Risk Calculator
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation ischemic stroke MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top